TY - JOUR
T1 - Childhood lymphomatoid granulomatosis
T2 - A report of 2 cases and review of the literature
AU - Tacke, Zwanique C.A.
AU - Eikelenboom, M. Judith
AU - Vermeulen, R. Jeroen
AU - Van Der Knaap, Marjo S.
AU - Euser, Anne M.
AU - Van Der Valk, Paul
AU - Kaspers, Gertjan J.L.
N1 - Publisher Copyright:
Copyright © 2013 by Lippincott Williams & Wilkins.
PY - 2014/10/8
Y1 - 2014/10/8
N2 - Lymphomatoid granulomatosis (LG) is a B-cell type lymphoproliferative disease. It mainly affects the lungs but may have extrapulmonary manifestations, especially in the central nervous system. The purpose of this study was to review the pediatric cases in the literature and add 2 new cases to the existing literature. A review of the literature was performed on children (0 to 18 years of age at diagnosis) with pathologically proven LG. We found 47 case reports, which, together with 2 new cases, were systematically analyzed. The median age was 12 years. The main symptoms were general, pulmonary, and neurological. Approximately one third of the patients were immunocompromised. High mortality rate was observed. Pediatric LG is a rare disease, which appears to be more frequently seen in immunocompromised patients, especially patients with leukemia. The disease has a high mortality rate; therefore, aggressive therapy according to a highgrade B-cell lymphoma protocol is justified.
AB - Lymphomatoid granulomatosis (LG) is a B-cell type lymphoproliferative disease. It mainly affects the lungs but may have extrapulmonary manifestations, especially in the central nervous system. The purpose of this study was to review the pediatric cases in the literature and add 2 new cases to the existing literature. A review of the literature was performed on children (0 to 18 years of age at diagnosis) with pathologically proven LG. We found 47 case reports, which, together with 2 new cases, were systematically analyzed. The median age was 12 years. The main symptoms were general, pulmonary, and neurological. Approximately one third of the patients were immunocompromised. High mortality rate was observed. Pediatric LG is a rare disease, which appears to be more frequently seen in immunocompromised patients, especially patients with leukemia. The disease has a high mortality rate; therefore, aggressive therapy according to a highgrade B-cell lymphoma protocol is justified.
KW - B-cell lymphoma
KW - Children
KW - Cns
KW - Epstein-barr virus
KW - Lymphomatoid granulomatosis
UR - http://www.scopus.com/inward/record.url?scp=84910112640&partnerID=8YFLogxK
U2 - 10.1097/MPH.0000000000000090
DO - 10.1097/MPH.0000000000000090
M3 - Review article
C2 - 24390446
AN - SCOPUS:84910112640
SN - 1077-4114
VL - 36
SP - e416-e422
JO - Journal of Pediatric Hematology/Oncology
JF - Journal of Pediatric Hematology/Oncology
IS - 7
ER -